Literature DB >> 16479007

Inquiring into the differential action of interferons (IFNs): an IFN-alpha2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-beta.

Diego A Jaitin1, Laila C Roisman, Eva Jaks, Martynas Gavutis, Jacob Piehler, Jose Van der Heyden, Gilles Uze, Gideon Schreiber.   

Abstract

Alpha and beta interferons (IFN-alpha and IFN-beta) are multifunctional cytokines that exhibit differential activities through a common receptor composed of the subunits IFNAR1 and IFNAR2. Here we combined biophysical and functional studies to explore the mechanism that allows the alpha and beta IFNs to act differentially. For this purpose, we have engineered an IFN-alpha2 triple mutant termed the HEQ mutant that mimics the biological properties of IFN-beta. Compared to wild-type (wt) IFN-alpha2, the HEQ mutant confers a 30-fold higher binding affinity towards IFNAR1, comparable to that measured for IFN-beta, resulting in a much higher stability of the ternary complex as measured on model membranes. The HEQ mutant, like IFN-beta, promotes a differentially higher antiproliferative effect than antiviral activity. Both bring on a down-regulation of the IFNAR2 receptor upon induction, confirming an increased ternary complex stability of the plasma membrane. Oligonucleotide microarray experiments showed similar gene transcription profiles induced by the HEQ mutant and IFN-beta and higher levels of gene induction or repression than those for wt IFN-alpha2. Thus, we show that the differential activities of IFN-beta are directly related to the binding affinity for IFNAR1. Conservation of the residues mutated in the HEQ mutant within IFN-alpha subtypes suggests that IFN-alpha has evolved to bind IFNAR1 weakly, apparently to sustain differential levels of biological activities compared to those induced by IFN-beta.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16479007      PMCID: PMC1430259          DOI: 10.1128/MCB.26.5.1888-1897.2006

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  51 in total

1.  Structure of the interferon-receptor complex determined by distance constraints from double-mutant cycles and flexible docking.

Authors:  L C Roisman; J Piehler; J Y Trosset; H A Scheraga; G Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

2.  Mechanisms for regulation of cellular responsiveness to human IFN-beta1a.

Authors:  Stefan A Dupont; Susan Goelz; Jaya Goyal; Marie Green
Journal:  J Interferon Cytokine Res       Date:  2002-04       Impact factor: 2.607

Review 3.  Review: IFN-alpha/beta receptor interactions to biologic outcomes: understanding the circuitry.

Authors:  Melissa M Brierley; Eleanor N Fish
Journal:  J Interferon Cytokine Res       Date:  2002-08       Impact factor: 2.607

Review 4.  Full house: 12 receptors for 27 cytokines.

Authors:  Sergei V Kotenko; Jerome A Langer
Journal:  Int Immunopharmacol       Date:  2004-05       Impact factor: 4.932

5.  Differential IL-10R1 expression plays a critical role in IL-10-mediated immune regulation.

Authors:  Y Ding; L Qin; D Zamarin; S V Kotenko; S Pestka; K W Moore; J S Bromberg
Journal:  J Immunol       Date:  2001-12-15       Impact factor: 5.422

6.  Novel growth and death related interferon-stimulated genes (ISGs) in melanoma: greater potency of IFN-beta compared with IFN-alpha2.

Authors:  Douglas W Leaman; Mamta Chawla-Sarkar; Barbara Jacobs; Keyur Vyas; Yaping Sun; Aylin Ozdemir; Taolin Yi; Bryan R Williams; Ernest C Borden
Journal:  J Interferon Cytokine Res       Date:  2003-12       Impact factor: 2.607

7.  The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression.

Authors:  Josiane Ragimbeau; Elisabetta Dondi; Andrés Alcover; Pierre Eid; Gilles Uzé; Sandra Pellegrini
Journal:  EMBO J       Date:  2003-02-03       Impact factor: 11.598

Review 8.  The natural alliance between type I interferon and dendritic cells and its role in linking innate and adaptive immunity.

Authors:  Stefano M Santini; Tiziana Di Pucchio; Caterina Lapenta; Stefania Parlato; Mariantonia Logozzi; Filippo Belardelli
Journal:  J Interferon Cytokine Res       Date:  2002-11       Impact factor: 2.607

9.  Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells.

Authors:  Eliana M Coccia; Martina Severa; Elena Giacomini; Danièle Monneron; Maria Elena Remoli; Ilkka Julkunen; Marina Cella; Roberto Lande; Gilles Uzé
Journal:  Eur J Immunol       Date:  2004-03       Impact factor: 5.532

10.  SCF(HOS) ubiquitin ligase mediates the ligand-induced down-regulation of the interferon-alpha receptor.

Authors:  K G Suresh Kumar; Weigang Tang; Abhilash K Ravindranath; William A Clark; Ed Croze; Serge Y Fuchs
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

View more
  106 in total

Review 1.  Cytokine-receptor interactions as drug targets.

Authors:  Gideon Schreiber; Mark R Walter
Journal:  Curr Opin Chem Biol       Date:  2010-07-07       Impact factor: 8.822

2.  Contrasting effects of human, canine, and hybrid adenovirus vectors on the phenotypical and functional maturation of human dendritic cells: implications for clinical efficacy.

Authors:  Matthieu Perreau; Franck Mennechet; Nicolas Serratrice; Joel N Glasgow; David T Curiel; Harald Wodrich; Eric J Kremer
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

3.  Determination of the two-dimensional interaction rate constants of a cytokine receptor complex.

Authors:  Martynas Gavutis; Eva Jaks; Peter Lamken; Jacob Piehler
Journal:  Biophys J       Date:  2006-02-10       Impact factor: 4.033

4.  The EM structure of a type I interferon-receptor complex reveals a novel mechanism for cytokine signaling.

Authors:  Zongli Li; Jennifer Julia Strunk; Peter Lamken; Jacob Piehler; Thomas Walz
Journal:  J Mol Biol       Date:  2007-12-08       Impact factor: 5.469

5.  Ligand-independent pathway that controls stability of interferon alpha receptor.

Authors:  Jianghuai Liu; Alexander Plotnikov; Anamika Banerjee; K G Suresh Kumar; Josiane Ragimbeau; Zrinka Marijanovic; Darren P Baker; Sandra Pellegrini; Serge Y Fuchs
Journal:  Biochem Biophys Res Commun       Date:  2007-12-31       Impact factor: 3.575

6.  Defining the distinct, intrinsic properties of the novel type I interferon, IFNϵ.

Authors:  Sebastian A Stifter; Antony Y Matthews; Niamh E Mangan; Ka Yee Fung; Alexander Drew; Michelle D Tate; Tatiana P Soares da Costa; Daniel Hampsey; Jemma Mayall; Phil M Hansbro; Albert Garcia Minambres; Sahar G Eid; Johnson Mak; Judy Scoble; George Lovrecz; Nicole A deWeerd; Paul J Hertzog
Journal:  J Biol Chem       Date:  2017-11-29       Impact factor: 5.157

7.  Receptor density is key to the alpha2/beta interferon differential activities.

Authors:  Ignacio Moraga; Daniel Harari; Gideon Schreiber; Gilles Uzé; Sandra Pellegrini
Journal:  Mol Cell Biol       Date:  2009-06-29       Impact factor: 4.272

8.  Stochastic receptor expression determines cell fate upon interferon treatment.

Authors:  Doron Levin; Daniel Harari; Gideon Schreiber
Journal:  Mol Cell Biol       Date:  2011-06-20       Impact factor: 4.272

Review 9.  Interferon-stimulated genes: a complex web of host defenses.

Authors:  William M Schneider; Meike Dittmann Chevillotte; Charles M Rice
Journal:  Annu Rev Immunol       Date:  2014-02-06       Impact factor: 28.527

10.  Conformation and dynamics of biopharmaceuticals: transition of mass spectrometry-based tools from academe to industry.

Authors:  Igor A Kaltashov; Cedric E Bobst; Rinat R Abzalimov; Steven A Berkowitz; Damian Houde
Journal:  J Am Soc Mass Spectrom       Date:  2009-10-29       Impact factor: 3.109

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.